Customized Use of Anti-Tumour Necrosis Factor-α Therapy During Pregnancy

被引：0

作者：

Seow, Cynthia H. ^{[1
]}

Casteele, Niels Vande ^{[2
]}

Panaccione, Remo ^{[1
]}

机构：

[1] Univ Calgary, Dept Med, Calgary, AB, Canada

[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA

来源：

JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷 / 11期

关键词：

ADALIMUMAB; INFLIXIMAB;

D O I：

10.1093/ecco-jcc/jjy082

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1379 / 1380

页数：2

共 50 条

[1] Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy [J].

Yoo, Jung-Wan ;

Jo, Kyung-Wook ;

Kang, Bo-Hyung ;

Kim, Mi Young ;

Yoo, Bin ;

Lee, Chang-Keun ;

Kim, Yong-Gil ;

Yang, Suk-Kyun ;

Byeon, Jeong-Sik ;

Kim, Kyung-Jo ;

Ye, Byong Duk ;

Shim, Tae Sun .

EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (05) :1289-1295

[2] Anti-tumour necrosis factor-α therapies in Crohn's disease [J].

Sprakes, M. B. ;

Hamlin, P. J. .

BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (11) :644-647

[3] Increased Serum Tumour Necrosis Factor-α in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-α Agents? [J].

Matusiak, Lukasz ;

Bieniek, Andrzej ;

Szepietowski, Jacek C. .

ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) :601-603

[4] Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy [J].

Schnarr, S ;

Kuipers, JG ;

Zeidler, H .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) :S126-S129

[5] Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-α Therapy in Ankylosing Spondylitis [J].

Filip De Keyser ;

Dominique Baeten ;

Filip Van den Bosch ;

Elli Kruithof ;

Gust Verbruggen ;

Herman Mielants ;

Eric Veys .

Drugs, 2004, 64 :2793-2811

[6] Anti-tumour necrosis factor-α treatment for perianal Crohn's disease in Australia [J].

Burger, Daniel C. ;

Lawrance, Ian C. ;

Bampton, Peter A. ;

Prosser, Ruth ;

Croft, Anthony ;

Gilshenan, Kristen ;

Radford-Smith, Graham L. ;

Florin, Timothy H. .

MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (07) :375-377

[7] Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema [J].

Tosi, G. M. ;

Vitale, A. ;

Rigante, D. ;

Sota, J. ;

Emmi, G. ;

Lopalco, G. ;

Guerriero, S. ;

Iannone, F. ;

Vannozzi, L. ;

Bitossi, A. ;

Frediani, B. ;

Cantarini, L. ;

Fabiani, C. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) :621-625

[8] Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical Implications [J].

Rogler, Gerhard ;

Biedermann, Luc ;

Scharl, Michael .

DIGESTIVE DISEASES, 2017, 35 (1-2) :5-12

[9] Role of anti-tumour necrosis factor-α therapeutic agents in the emergence of infections [J].

Moiton, M. P. ;

Richez, C. ;

Dumoulin, C. ;

Mehsen, N. ;

Dehais, J. ;

Schaeverbeke, T. .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (12) :1151-1153

[10] Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remission [J].

Brooks, A. J. ;

Sebastian, S. ;

Cross, S. S. ;

Robinson, K. ;

Warren, L. ;

Wright, A. ;

Marsh, A. M. ;

Tsai, H. ;

Majeed, F. ;

McAlindon, M. E. ;

Preston, C. ;

Hamlin, P. J. ;

Lobo, A. J. .

JOURNAL OF CROHNS & COLITIS, 2017, 11 (12) :1456-1462

← 1 2 3 4 5 →